PLANTATION, FL, and GAITHERSBURG, MD, USA I January 28, 2025 I miRecule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading contract development and manufacturing ...

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

(MENAFN- PR Newswire) Under the agreement, GBI will leverage its expertise and state-of-the-art facilities to support miRecule in the development and clinical production of its ARC therapies.

miRecule, a biotechnology company focusing on RNA therapies, and GBI Biomanufacturing, a CDMO, partnered to advance the development and clinical supply of miRecule’s Antibody-RNA Conjugate (ARC ...

PLANTATION, Fla. and GAITHERSBURG, Md., Jan. 28, 2025 /PRNewswire/ -- miRecule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading contract development and ...

Researchers at the University of Pittsburgh have developed a new way to grow T cells in the lab that enables the cells to live longer and better destroy cancer cells in a mouse model of melanoma ...